Healthcare and Medical Businesses

Health is a primary human right and has been accorded due importance by the Constitution through Article 21.Though Article 21 stresses upon state governments to safeguard the health and nutritional well being of the people, the central government also plays an active role in the sector. Recognizing the critical role played by the Health Industry, the industry has been conferred with the infrastructure status under section 10(23G) of the Income Act.

The healthcare sector is one of the most challenging and fastest growing sectors in India. Revenues from the healthcare sector account for 5.2 per cent of the GDP, making it the third largest growth segment in India.

The Indian Health sector consists of

-Medical care providers like physicians, specialist clinics, nursing homes, hospitals.

-Diagnostic service centers and pathology laboratories.

-Medical equipment manufacturers.

-Contract research organizations (CRO's), pharmaceutical manufacturers

-Third party support service providers (catering, laundry)

The healthcare industry in the country, which comprises hospital and allied sectors, is projected to grow 23 per cent per annum. According to McKinsey & Co. a leading industrial and management consulting organization, the Indian healthcare sector, including pharmaceutical, diagnostics and hospital services, is expected to more than double its revenues to Rs 2000 billion by 2010. Expenditure on healthcare services, including diagnostics, hospital occupancy and outpatient consulting, the largest component of this spend is expected to grow more than 125% to Rs 1560 billion by 2012 from Rs 690 billion now.

The sector has registered a growth of 9.3 per cent between 2000-2009, comparable to the sectoral growth rate of other emerging economies such as China, Brazil and Mexico. According to the report, the growth in the sector would be driven by healthcare facilities, private and public sector, medical diagnostic and pathology labs and the medical insurance sector.

Healthcare facilities, inclusive of public and private hospitals, the core sector, around which the healthcare sector is centered, would continue to contribute over 70 per cent of the total sector and touch a figure of US$ 54.7 billion by 2012. Adds a FICCI-Ernst and Young report, India needs an investment of US$ 14.4 billion in the healthcare sector by 2025, to increase its bed density to at least two per thousand populations.

Technological advances achieved by medicare globally in the recent years have been phenomenal. The Indian scenario has not remained immune to these changes. While IT (information technology) has come to the aid of the breakthroughs, the progress recorded in the medicare area is as impressive as it is in the IT sector itself. The changes are in concepts, forms and content, as well as applications. These are both, quantitative and qualitative. The transformation is pervasive and has penetrated almost all specialities, from diagnostics to physiotherapy, from cardiology to oncology, from non-invasive surgery to transplants. In India, the emergence of private medicare services, especially through commercialization and corporatization, has contributed to the transformation. The rapid commercialization of the medical practices with the establishment of multi-million rupee hospitals, nursing homes and diagnostic centres, specialized and general, the demand has registered a very high growth rate in the recent years.

Medical sector in India got tax exemptions in the manufacturing of its devices from Union Budget 2010-11 along with the introduction of excellent initiatives towards the development of the sector. The FM has proposed to extend the tax exemption on medical apparatus and devices and concessional tariff available to certified government hospitals. Moreover, the producers of orthopaedic implants have been relieved from import tax.

The incentives proposed by the FM are expected to trigger the expansion of already fast developing medical apparatus and machinery sector in India. By 2010 the medical apparatus and machinery industry is estimated to reach USD 1.8 billion and is projected to expand at a rate of 23% on annual basis as per the NIPER report.

This time the focus of the budget was on rural healthcare, with the fund allocations rising to a whopping 22,300 crores (Rs 223 billion/$4.82 billion) from 19,534 crores during the previous fiscal year. This escalation is in keeping with the evolving needs of the growing healthcare industry of the country. Relaxation of FDI norms may see more international players coming in to India in the healthcare sector. Added to it, rationalization of duties on medical equipment can make imports cheaper and can significantly lower healthcare costs in the country in the coming years.

The government, along with participation from the private sector, is planning to invest US$ 1 billion to US$ 2 billion in an effort to make India one of the top five global pharmaceutical innovation hubs by 2020. The sector has been attracting huge investments from domestic players as well as financial investors and private equity (PE) firms. The Indian market is expanding in all directions as a result of better affordability, greater health consciousness and expanding medical service institutions.

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 11 of 12 | Total 113 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Vitamin ‘C’

Vitamin C is a physiological antioxidant of major importance for protection against diseases and degenerative processes caused by oxidative stress. Vitamin C is ubiquitous. It is found throughout the plant and animal kingdoms, where its roles are often not known or are poorly understood. The synthetic vitamin is very widely used as a food additive and therefore has an E number (E300). The global Ascorbic Acid market is expected to witness moderate growth over the forecast period on account of increasing demand from pharmaceutical industry. The majority of ascorbic acid manufactured is used as an antioxidant. The major end-user industries of ascorbic acid are pharmaceuticals, food & beverages, personal care, and others. The pharmaceutical industry is the largest consumer of ascorbic acid. Vitamin C helps to recycle vitamin E. About one-third of the total production of ascorbic acid is used for vitamin preparations in the pharmaceutical industry. The rest is mainly applied as an additive to food and feed to enhance product quality and stability. Vitamin C Market is driven due to rising health awareness and need for healthy lifestyle. Thus, due to demand it is a good project for entrepreneurs to invest. Few Indian major players are as under • Manav Drugs • A.B. Enterprises • TriveniInterchem Pvt. Ltd. • Estrellas Life Sciences Pvt. Ltd. • Akhil Healthcare Private Limited
Plant capacity: 2400 MT/annumPlant & machinery: Rs 123 lakhs
Working capital: -T.C.I: Cost of Project : Rs 563 lakhs
Return: 29.00%Break even: 50.00%
Add to Inquiry Add to Inquiry Basket

Baby Cereal Food

The Baby-cereal-foods is that enriched food which has a requisite level of nutrition. This requisite level is prescribed by various dietitians & physicians for children. Various experts fixed a definite calorific value for infant food & based on this the various mixtures or formulae of foods are developed. Food products are derived from single grains or blends of mixed grains combined with other ingredients for flavour and nutritional fortification. Materials used by various manufacturers in addition to the grains include malt, milk powder, vegetable oil, wheat germ, sugar, cotton seed flour, tri and dicalcium phosphate, dried yeast, a form of iron such as sodium iron pyrophosphate and the vitamin B1 (thiamin), riboflavin and niacin. The baby food market in India is witnessing rapid growth and is growing by 10-12% a year. India has the largest population of 0-4 year old in Asia. Additionally, due to the increasing number of working women, and the increasing parental concerns about nutrition have lead to its growth. Professionally-made food designed to meet the nutrition requirements of babies also address the problems of paucity of time for preparing baby food at home.As a whole it is a good project for new entrepreneurs to invest. Few Indian major players are as under • Continental Milkose (India) Ltd. • Glaxosmithkline Consumer Healthcare Ltd. • Hindustan Foods Ltd. • Kaira District Co-Op. Milk Producers' Union Ltd. • Narayan Agro Foods Ltd. • Natureland Organic Foods Pvt. Ltd. • Nestle India Ltd.
Plant capacity: Baby Cereal Food (Packing in 225 gms Size Packet): 600,000 Kgs/annumPlant & machinery: Rs 35 lakhs
Working capital: -T.C.I: Cost of Project : Rs 82 lakhs
Return: 32.00%Break even: 72.00%
Add to Inquiry Add to Inquiry Basket

Diaper (Baby and Adult) and Sanitary Napkins Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

A diaper (American English) or a nappy (British English) is a type of underwear that allows the wearer to defecate or urinate without the use of a toilet, by absorbing or containing waste products to prevent soiling of outer clothing or the external environment. When diapers become soiled, they require changing, generally by a second person such as a parent or caregiver. Failure to change a diaper on a sufficiently regular basis can result in skin problems around the area covered by the diaper. Diapers are made of cloth or synthetic disposable materials. Cloth diapers are composed of layers of fabric such as cotton, hemp, bamboo, microfiber, or even plastic fibers such as PLA, and can be washed and reused multiple times. Disposable diapers contain absorbent chemicals and are thrown away after use. Plastic pants can be worn over diapers to avoid leaks, but with modern cloth diapers, this is no longer necessary. An adult diaper (or adult nappy) is a diaper made to be worn by a person with a body larger than that of an infant or toddler. Diapers can be necessary for adults with various conditions, such as incontinence, mobility impairment, severe diarrhea or dementia. Adult diapers are made in various forms, including those resembling traditional child diapers, underpants, and pads resembling sanitary napkins (known as incontinence pads). A sanitary napkin, sanitary towel, sanitary pad, menstrual pad, or pad is an absorbent item worn by a woman while she is menstruating, while she is recovering from vaginal surgery, for lochia (post-birth bleeding), after an abortion, or in any other situation where it is necessary to absorb a flow of blood from the vagina. These pads are not to be confused with generally higher absorbency incontinence pads, which are worn by men or women who have urinary incontinence problems or experience stress incontinence. Menstrual pads may be used by some people for this purpose. ? Why is the Demand for Adult Diapers Predicted to Increase? • Growing aging population • Urbanization • Increased awareness of treatment methods for urinary incontinence • Economic affluence • Improvements in the healthcare sector Market Outlook Rising birth rates have ensured that the baby diapers market, growing at a healthy 18-20 per cent year on year, is estimated to reach Rs. 11,964 crore by 2017, with three nations accounting for the massive jump. The diaper market in West Asia and Africa is growing at a fast clip, with babies in these regions expected to use about 8 billion diapers a year by 2017. In India, the baby diaper market is currently pegged at Rs. 1,400 crore. Supported by favourable demographics with 26 million babies born in India every year, the potential is huge. “The diaper market is experiencing a surge in demand for sanitation products. The diaper market in India is growing with more than 20% CAGR from the last seven years. The healthy growth rate is driven by factors such as millions of babies born per year, higher disposable incomes and the increased hygiene awareness of Indian mothers. Global baby diapers market is expected to garner $59.4 billion by 2020. The global baby diaper market covers different types of diapers provided by the manufacturers within the baby diapers. The different types of diapers manufactured around the globe are Cloth diapers, Disposable diapers, Training nappy, Swim pants and Bio-degradable diapers. The global baby diaper market is anticipated to expand at a CAGR of 4.1% during the forecast period and is expected to be valued at US$ 70.4 Bn by 2024 end. Among all product type segments in the baby diaper industry, disposable diapers are projected to be the fastest-growing segment over the forecast period (2016-2024). This segment accounts for approximately 49.0% of the global volume of diapers consumed; attributed to the availability of improved raw materials and technological advancements in markets in various regions across the globe. Global disposable diapers market size of about USD 64.4 billion in 2014, global disposable diaper market size is expected to reach about USD 84.7 billion by 2019. Global adult diapers market was valued at USD 9,246.36 million in 2015 and is expected to reach USD 14,592.72 million by 2021, growing at a CAGR of 7.50% between 2016 and 2021. In terms of volume, the global adult diapers market stood at 17,689.3 million units in 2015. The global sanitary napkin market to grow at a CAGR of 4.6% during the period 2016-2020. Tags Investment Opportunities in India Sanitary Napkin Project, Sanitary Pads Market in India, Sanitary Napkin Machine, Low Cost Sanitary Napkin Making Machine, Project Profile for Sanitary Napkins, Diaper Manufacture Business Plan, Baby Diaper Manufacture, Baby Diaper Manufacturing Machine, Disposable Diaper Industry, Diaper Manufacturing Machine, Diaper Manufacturing in India, Disposable Diaper Manufacturing, Disposable Baby Diaper Manufacture, Diaper Manufacturing Business Plan in India, Baby Diaper & Sanitary Napkins Manufacturing Plant, Baby Diaper Manufacturing, Diaper Manufacturing Business, Baby Diaper Manufacturing Plant, Diaper Production Plant, Diaper Manufacturing Business Plan, Diaper Manufacturing Process, Diaper Manufacturing Project Report, Diaper Manufacturing Plant, Manufacturing Process of Disposable Diaper, Baby Diaper Production Line, Report on Diapers Manufacturing in India, Start Diaper Manufacturing Business, Adult Diapers Manufacture, Adult Diaper Production Line, Adult Diaper Making Machine, Adult Diaper Production, Adult Diaper Manufacturing Machine, Adult Diaper Manufacturing Process, Manufacturing Process Of Adult Diaper, Adult Diapers Industry, Baby & Adult Diaper & Sanitary Pads Manufacturing Plant, How to Start Diaper Manufacturing Business, Sanitary Napkin Manufacturing Business Plan, Sanitary Napkin Manufacturing, Sanitary Napkins Manufacturing Plant, Low Cost to Setup Mini Sanitary Napkin Manufacturing, Sanitary Napkin Making Machine, Sanitary Napkins Manufacturing Unit, Low Cost Sanitary Napkin Making Machine, Sanitary Napkin Manufacturing Machine, Sanitary Napkin Project, Sanitary Napkin Manufacturing Project, Sanitary Napkin Business Plan, Sanitary Napkin Business Opportunity, How to Make Sanitary Napkins, Sanitary Pad Manufacturing Business Plan, Sanitary Napkin Production, Sanitary Pads Making Machine, Manufacturing of Sanitary Napkins, Sanitary Napkin Manufacture, How to Start Sanitary Napkin Manufacturing, Sanitary Napkin Manufacturing Process, Start Sanitary Napkins Manufacturing, Methods of Making Sanitary Napkins, Method of Manufacturing Sanitary Napkin, Production of Baby Diapers & Sanitary Napkins, Manufacturing Equipment for Sanitary Napkins, Sanitary Napkin Production Project Ideas, Projects on Small Scale Industries, Small Scale Industries Projects Ideas, Adult Diaper Manufacturing Based Small Scale Industries Projects, Project Profile on Small Scale Industries, How to Start Sanitary Napkin Industry In India, Baby Diaper Manufacturing Projects, New Project Profile on Baby Diaper Manufacturing Industries, Project Report on Adult Diaper Manufacturing Industry, Detailed Project Report on Adult Diaper Manufacturing, Project Report on Sanitary Napkin Production, Pre-Investment Feasibility Study on Sanitary Napkin Production, Techno-Economic Feasibility Study on Baby Diaper Manufacturing, Feasibility Report on Baby Diaper Manufacturing, Free Project Profile on Adult Diaper Manufacturing, Project Profile on Diaper Manufacturing, Download Free Project Profile on Sanitary Napkin Production, Industrial Project Report, Project Consultant, Project Consultancy, Npcs, Niir, Process Technology Books, Business Consultancy, Business Consultant, Project Identification and Selection, Preparation of Project Profiles, Startup, Business Guidance, Business Guidance to Clients, Startup Project for Sanitary Napkin Production, Startup Project, Startup Ideas, Project for Startups, Startup Project Plan, Business Start-Up, Business Plan for Startup Business, Great Opportunity for Startup, Small Start-Up Business Project, Project Report for Bank Loan, Project Report for Bank Finance, Project Report Format for Bank Loan in Excel, Excel Format of Project Report and CMA Data, Project Report Bank Loan Excel, Detailed Project Plan Reports
Plant capacity: Baby Diapers : 3000000 Pkts/annum Adult Diapers : 1500000 Pkts/annum Sanitary Napkins : 4500000 Pkts/annumPlant & machinery: 1029 lakhs
Working capital: -T.C.I: Cost of Project : 1657 lakhs
Return: 29.00%Break even: 51.00%
Add to Inquiry Add to Inquiry Basket

I.V. Fluids

Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. Many companies manufacture packaged intravenous fluids, as well as products which can be mixed with sterile water to prepare a solution for intravenousadministration. I.V. fluids or Intravenous fluids are life saving drugs, which are widely used in surgery, pediatrics, urology, obstetrics and gynecology. They are given mostly to patients suffering from dehydration, diarrhoea, vomiting, gastroenteritis and excessive perspiration. The growth of the global intravenous solutions market is driven by several factors. The increasing incidence of gastrointestinal disorders, diabetes, and cancer is one of the major factors that are expected to increase the rate of adoption of intravenous solutions among consumers. Thus, due to demand it is a good project for entrepreneurs to invest. Few Indian Major Players are as under • AxaParenterals Ltd. • D.J. Laboratories Pvt. Ltd. • Baxter International Inc. • Amanta Healthcare • Aishwarya Healthcare
Plant capacity: I.V. Fluid (500 ml.):14,400,000 Bottles/annumPlant & machinery: Rs 476 lakhs
Working capital: -T.C.I: Cost of Project: Rs 1092 lakhs
Return: 26.00%Break even: 53.00%
Add to Inquiry Add to Inquiry Basket

Surgical Cotton

Surgical cotton is also known as absorbent cotton” or “cotton wool”. Surgical/Absorbent cotton is cleared de-oiled and bleached cotton packed in different sizes. Since Surgical/Absorbent cotton is a material which comes in direct contact with the human body, its quality is very important and should satisfy the required pharmaceutical parameters. The fiber of Surgical/Absorbent cotton is very elastic. It consists of 98%-99.5% of cellulose which has a diameter of 16.30 and a length of 12-40 mm. Today, India produces the widest range of cotton; perhaps no other cotton producing country in the world has this distinction.Progressive increase in health amenities offered by Government and coming up of new hospitals and health care centres in private sector even at small towns are contributing to the growth of absorbent cotton industry. The demand for absorbent cotton is directly related with the development and expansion of health facilities in the country. The Federal and Regional Governments have given high attention for expansion of health facilities to increase the coverage. Hence, considering the population growth and the high attention given by the Federal and Regional Governments, the demand for absorbent cotton is assumed to grow by 10%, annually.As a whole there is a good scope for new entrepreneur to invest in this business. Few Indian Major Players are as under: • JajooSurgicals Pvt. Ltd. • Mohini Fibers Limited • Pradeep Surgical Dressings Pvt. Ltd. • Medicare Healthcare Product • Bafna Healthcare Pvt. Ltd. • BVM Meditech Private Limited • Patco Exports Pvt. Ltd. • Spartan Surgicals Pvt. Ltd. • Sri Sambasiva Cotton Private Limited • Saket Cottons Private Limited
Plant capacity: Surgical Cotton :300,000kgs/annumPlant & machinery: Rs 69 lakhs
Working capital: -T.C.I: Cost of Project: Rs 238 lakhs
Return: 26.00%Break even: 57.00%
Add to Inquiry Add to Inquiry Basket

Protein Bar

Protein bars, which contain some form of milk-derived or plant-based protein like whey, hemp, pea or rice protein. Protein bars are usually lower in carbs than energy bars, lower in vitamins and dietary minerals than meal replacement bars, and significantly higher in protein than either. Protein bars may contain high levels of sugar and sometimes are called "candy bars" in disguise. Protein bars include isolated protein from one or more sources; for example, milk, soy or eggs. An energy bar should have 3 grams of fiber or more and up to 15 grams of protein. The combined market for cereal/granola bars and energy/nutrition bars is projected to approach $8.3 billion in 2016, for a compound annual growth rate (CAGR) of 7.5% over the five-year 2012 to 2016 periods. The market is growing at a fast rate, due to the increasing demand among consumers for portable convenience foods, which is enhancing the protein bar market. These consumers are not only sports athletes, but also those who want to have a wholesome meal without the trouble of cooking and prefer buying protein bars. Globally, the market for protein bars is expected to register a CAGR of XX% from 2018 to 2023. The protein bar market is estimated to be valued at USD XX million in 2017 and is projected to reach USD XX million by 2023. As a whole entrepreneur can venture in this field will be successful. Few Indian major players are as under • Birla Research & Life sciences Ltd. • Cosmic Kitchen Pvt. Ltd. • Dukes Products (India) Ltd. • Innovative Foods Ltd. • Naturell (India) Pvt. Ltd. • Natures Basket Ltd.
Plant capacity: 40000 Pcs./dayEach pcs 50 gmsPlant & machinery: 129 lakhs
Working capital: -T.C.I: Cost of Project: Rs 644 lakhs
Return: 32.00%Break even: 50.00%
Add to Inquiry Add to Inquiry Basket

Dental Materials (Alginate, GI Cement, Composite Resin & Polycarboxylate Cement)

A dental impression is a negative imprint of hard (teeth) and soft tissues in the mouth from which a positive reproduction (cast or model) can be formed. Impression material is of liquid or semi-solid nature when first mixed and placed in the mouth. It then sets to become an elastic solid (usually takes a few minutes depending upon the material), leaving an imprint of person's dentition and surrounding structures of oral cavity. Alginate is an irreversible hydrocolloid. It exists in two phases: either as a viscous liquid, or a solid gel, the transition generated by a chemical reaction. The overall setting double composition reaction is as follows: Potassium (sodium) alginate + calcium sulphate dihydrate + water ? calcium alginate + potassium (sodium) sulphate Sodium phosphate is added as a retarder which preferentially reacts with calcium ions to delay the set of the material. The market has been estimated at USD 6.2 billion in 2016 and is projected to reach USD 8.5 billion by 2021, at a CAGR of 6.5% during the forecast period from 2016 to 2021. Dental equipment is tools used to diagnose and treat dental diseases. Dental tools are used by dental professionals to examine, manipulate, restore and remove teeth and surrounding oral structures and to provide dental treatment. The end-users for this market include hospitals, dental clinics, and dental practitioners. The Global Restorative Dentistry Market is projected to Reach USD 21.27 Billion by 2022 from USD 15.60 Billion in 2017, at a CAGR of 6.4% Increase in the prevalence of dental diseases (dental caries and edentulism), rising demand for advanced cosmetic dental procedures, growing dental tourism, and increasing dental expenditure are the major factors driving the demand for restorative dentistry. As a whole any entrepreneur can venture in this project without risk and earn profit.
Plant capacity: Composite Resin Poly Carboxylate Cement (500 gms Pack): 80 Packs/ Day Glass Ionomer Cement (15 gms Packs with 10 gm Liquid): 1333 Packs/ Day Composite Resin Poly Carboxylate Cement (500 gms Pack):40 Packs/ Day Plant & machinery: 26 lakhs
Working capital: -T.C.I: Cost of Project: Rs 71 lakhs
Return: 33.00%Break even: 75.00%
Add to Inquiry Add to Inquiry Basket

IV Fluids (BFS Technology)

Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. Many companies manufacture packaged intravenous fluids, as well as products which can be mixed with sterile water to prepare a solution for intravenous administration. Fluids are given when someone's body fluid volume falls. There are a number of things which can cause a drop in fluid volume. Vomiting and diarrhea are a classic example, which is why people are encouraged to drink fluids when they are sick, to keep their fluid volume stable. Another cause is blood loss, which causes problems both because people lose blood products, and because they experience a loss in fluid volume. Electrolyte levels in the blood can also become unstable as a result of rapid changes in fluid volume, in which case intravenous fluids can be used to restore the balance. India has the world's third largest active pharmaceutical ingredients (API) for the industry valued at a little less than USD 2 bn. Top 5 API producers account for approximately 6.5 %. The leading APIs are anti-infectives, gastrointestinal, cardiovascular and respiratory drugs. The Chemical Pharmaceutical Generic Association (CPA) projects that India's share of the world API market will grow by 10.5% by 2010 as patented blockbuster drugs lose their patent protection. The CPA also expects that the domestic Indian market for APIs, both generic and branded, will rise from USD 755 mn in 2005 to USD 1.9 bn in 2010.
Plant capacity: 48,000 Bottles/Day 500 ml each bottlePlant & machinery: 253 Lakhs
Working capital: N/AT.C.I: Cost of Project: 834 Lakhs
Return: 29.00%Break even: 52.00%
Add to Inquiry Add to Inquiry Basket

Production of I.V. Fluids (Saline and Dextrose). Intravenous Solution (IV) Manufacturing Business with Blow-Fill-Seal (BFS) Technology.

Fluids are given when someone's body fluid volume falls. There are a number of things which can cause a drop in fluid volume. Vomiting and diarrhea are a classic example, which is why people are encouraged to drink fluids when they are sick, to keep their fluid volume stable. Another cause is blood loss, which causes problems both because people lose blood products, and because they experience a loss in fluid volume. Electrolyte levels in the blood can also become unstable as a result of rapid changes in fluid volume, in which case intravenous fluids can be used to restore the balance. Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. Many companies manufacture packaged intravenous fluids, as well as products which can be mixed with sterile water to prepare a solution for intravenous administration. Intravenous fluids can be broken into two broad groups. Crystalloids such as saline solutions contain a solution of molecules which can dissolve in water. When crystalloids are administered, they tend to create low osmotic pressure, allowing fluid to move across the blood vessels, and this can be linked with edema. Colloids contain particles which are not soluble in water, and they create high osmotic pressure, attracting fluid into the blood vessels. Blood is an example of a commonly administered intravenous colloid. Infusion therapy as a basic toll of modern medical care enables the physician to restore and stabilize homeostasis states quickly and completely. In nursing homes and hospital where patients are suffering from acute dehydration or considerable debilitating conditions, the intra venous fluids are used as I.V. drips. The basic function of I.V. fluids is to replenish the body fluids. Although there are a number of I.V. fluids but generally three types of I.V. fluids are used in hospitals as I.V. drips. Uses and Applications There are main ranges of application of highly specialized intravenous infusion solutions: • Treatment of discarded water and electrolyte metabolism, especially in severe cases. • Therapy of acid base in balances. • The volume substitution and volume replacement in surgery of accident victim suffering blood loss. • Paratral nutrition for severally ill and post-operative patients. • Aqueous isotonic injection (5%) of dextrose is given as intravenous injections to increase the column of circulating blood in the shocks and haemorrhages and to counteract dehydration. When it is desired to replace excessive salt loss also glucose is injected along with sodium chloride. Intravenous fluids can also be used as a route of medication administration. If a doctor wants to delI.V.er a small amount of medication over an extended period of time, it can be dissolved in a bag of intravenous fluids and set on an infusion pump which delivers the medicated fluid directly into the blood. They are also commonly used to assist with surgical recovery; people who receive fluids after surgery tend to experience better recovery than people who do not. Intravenous Fluids Market is expected to witness growth of international market with respect to advancements and innovations including development history, competitive analysis and regional development forecast. The growth of the global intravenous solutions market is driven by several factors. The increasing incidence of gastrointestinal disorders, diabetes, and cancer is one of the major factors that are expected to increase the rate of adoption of intravenous solutions among consumers. The rising popularity of intravenous vitamin C therapy in cancer treatment is one of the major trends in the intravenous solutions market. The intravenous vitamin C solution has been observed to have an increased toxicity to cancer cells and improve the patients' quality of life. Intravenous fluids are extensively used to treat electrolyte imbalances, maintain fluid balance, and replace fluid losses. These fluids are dispensed in volumes ranging from 25-1,000 milliliters and are available in either plastic bags or glass bottles. A complete mixture of all essential nutrients is also available in multi-chamber bags, and these bags are gaining immense popularity among numerous end-users. The global Intravenous (I.V.) solutions market was valued at USD 6.9 billion in 2015 and is projected to grow at a CAGR of 7.8% over the forecast period. The emergence of this market is attributed to the fast growing geriatric population and prevalence of malnutrition in the elderly and pediatric population. Blow-Fill-Seal (BFS) Technology In blow-fill-seal (BFS) technology, which is a form of advanced aseptic manufacturing, the container is formed, filled, and sealed in one continuous, automated system. A primary advantage of this technology is reducing human intervention, which reduces the risk of microbial contamination and foreign particulates. BFS has long been used in liquid pharmaceutical applications, including small containers, such as ophthalmic and respiratory drug ampoules, as well as larger volume containers, such as saline or dextrose solutions. More recently, BFS technology has been expanding into injectable and into biologics, including vaccines and monoclonal antibodies (mAbs). Advantages of BFS Technology: • Blow-fill-seal technology enables the manufacture of preservative-free single-unit doses. PreservatI.V.es are recognized as potentially harmful to the sensitive mucosae of the eyes, nose, and lungs, so this is an enormous benefit to sensitive patients. • Another advantage of unit-doses is that they ensure that the patient takes the correct amount of product, especially when dealing with highly potent compounds, i.e. those therapeutically active at a low concentration. • Sterile unit-doses are portable and easy to use individually, excellent properties for today’s active lifestyles. Blow-fill-seal (BFS) single doses are an ideal solution for use in ophthalmology, respiratory diseases, rhinology, antisepsis and wound care. • Blow-fill-seal technology reduces personnel intervention making it a more robust method for the aseptic preparation of sterile pharmaceuticals. BFS is used for the filling of vials for parenteral preparations and infusions, eye drops, and inhalation products. Generally the plastic containers are made up of polyethylene and polypropylene. Polypropylene is more commonly used to form containers which are further sterilised by autoclaving as polypropylene has greater thermostability. • Blow Fill and Seal technology is mainly used for pharmaceutical solutions. The examples of pharmaceutical solutions that can be packaged are injectable solutions, antibiotics, ophthalmological drops, suspensions, infusion solutions, solutions for dialysis, solutions for irrigation and solutions for hemofiltration. The basic concept of BFS is that a container is formed, filled, and sealed in a continuous process without human intervention, in a sterile enclosed area inside a machine. Thus this technology can be used to aseptically manufacture sterile pharmaceutical liquid dosage forms. The process is multi-stepped: first, pharmaceutical-grade plastic resin is vertically heat extruded through a circular throat to form a hanging tube called the parison. This extruded tube is then enclosed within a two-part mould, and the tube is cut above the mould. The mould is transferred to the filling zone, or sterile filling space, where filling needles (mandrels) are lowered and used to inflate the plastic to form the container within the mould. Following the formation of the container, the mandrel is used to fill the container with liquid. Following filling the mandrels are retracted and a secondary top mould seals the container. All actions take place inside a sterile shrouded chamber inside the machine. The product is then discharged to a non-sterile area for labeling, packaging and distribution. The process begins with the Extrusion of plastic granules in the form of a hot hollow pipe of molten plastic called a parison. The following step is the Blow moulding of the container from the plastic granule. The parison is closed between the mould, and the container gets formed either by blowing sterile compressed air or by vacuum or by using vacuum as well as blowing. The container assumes the shape of the cavity in the mould. The container thus produced is open from the top and in its top part, the plastic is still hot and in molten state until the subsequent steps of filling and container sealing. The subsequent step is filling of the formed container from the top, which is still open (and still in a “hot molten” state). Filling nozzles enter from the top of container and filling is done. Filling nozzles are specially designed and constructed to facilitate automatic cleaning and automatic sterilization. Additional functions of filling nozzles are to blow the bottles and also to provide an exhaust path for air in the container. The filling process can be carried out under a shower of sterile filtered air to avoid contamination during filling. The blower on the sterile air shower can have variable pressure which can be made to change automatically so as to maintain constant air pressure under various situations. The sterile air shower is validated at certain air pressure, and an automatic device can maintain the same pressure by automatically modulating the speed of the blower. The next step is sealing the top of the container, which is still open and in a hot molten state. The top gets pressed between head moulds and as a consequence, the top part of the container gets formed, sealed and at the same time, gets cooled. The result is a hermetically sealed container. The final steps are for De-flashing to remove the flash or scrap, trimming the containers and delivering the containers outside the machine. The whole process of extrusion, blowing, filling, sealing and removing scrap takes between 10 to 18 seconds depending upon the type and size of the container. The advantage of the Blow-Fill-Seal process is derived mainly from the fact that container is formed, quickly filled and sealed under protected environment automatically without human intervention. BFS Machine Professional normal saline I.V. fluids packaging machine is the latest production line with most advanced technology. It can automatically finish film feeding, printing, bag making, filling and sealing in one machine. This BFS line can be used to automatically fill 50-5000ml general solution, special solution, dialysis solution, parenteral nutrition, Antibiotics, Irrigation and Disinfectant solution etc. Features: 1. 100% film utilization: No waste edge between bags, reducing both material and energy consumption. 2. Special I.V. bag design: each bag saves 10mm film than others. 3. Reliable heating and welding system: Leakage rate less than 0.03%. 4. Quick changeover: 0.5-1 hour to switch from one size to another. 5. Stable transmission system: only needs 1 control system, 1 HMI and 1 operator. 6. Safe filling nozzle: No solution overflows, no particles generation. 7. Auto faulty rejection system detected by the machine. 8. Production line length is reduced by 1/3, both workshop and air conditioning and cleaning area are reduced by 1/3, greatly reducing the initial investment and future running cost. 9. Simple structure, more stable and reliable performance. Tags I.V. Fluid Manufacturing Industry, I.V. Fluids Manufacturing Project Report, I.V. Fluids Manufacturing Process, Project Report for I.V. Fluid Plant, I.V. Fluids Manufacturing Equipment, IV Fluids Manufacturing Project Report, I.V. Fluid Manufacturing Plant in India, I.V. Fluids Manufacture, I.V. Fluid Production Plant, I.V. Fluid and Dialysis Solution Manufacturing, Project Report on Dextrose Saline (IV Fluid) Production, I.V. Fluids Production, I.V. Fluid Manufacturing Unit, IV Fluid Manufacturing Business, Pharma Manufacturing Unit in India, Pharmaceutical Company, Intravenous Fluid Production, Project Report on I.V. Fluid, IV Fluid Manufacturing Unit in India, I.V. Fluids Manufacturing Process, I.V. Fluids Manufacturing Equipment, Manufacturing Plant for I.V. Fluid, I.V. Fluid Manufacturing Machine, I.V. Fluids Manufacturing Project Report, IV Fluid Manufacturing Business, Manufacturing Plan of Intravenous Fluid, How to Start I.V. Fluid Production Business, I.V. Solution Manufacturing with BFS Technology, Blow-Fill-Seal Technology, Saline and Dextrose Fluid (IV Fluid) BFS Technology, Blow Fill Seal(BFS) Technology, Project Report on I.V. Fluid (BFS Technology), I.V. Fluid with BFS, Blow-Fill-Seal Machinery, I.V. Fluid Manufacturing using Blow–Fill–Seal Technology, I.V. Fluid Manufacturing project ideas, Projects on Small Scale Industries, Small scale industries projects ideas, IV Fluid Manufacturing Based Small Scale Industries Projects, Project profile on small scale industries, How to Start I.V. Fluid Manufacturing Industry in India, I.V. Fluid Manufacturing Projects, New project profile on I.V. Fluid Manufacturing industries, Project Report on IV Fluid Manufacturing Industry, Detailed Project Report on IV Fluid Manufacturing, Production of Intravenous Sugar Solution (Dextrose Solution), Saline and Dextrose Fluid (iv Fluid) BFS Technology, Production of Intravenous Sugar Solution, Project Report on I.V. Fluid Manufacturing, Pre-Investment Feasibility Study on IV Solution Manufacturing with BFS Technology, Techno-Economic feasibility study on I.V. Solution Manufacturing with BFS Technology, Feasibility report on I.V. Solution Manufacturing with BFS Technology, Free Project Profile on I.V. Solution Manufacturing with BFS Technology, Project profile on I.V. Solution Manufacturing with BFS Technology, Download free project profile on IV Solution Manufacturing with BFS Technology, Industrial Project Report, Project consultant, Project consultancy, Business guidance to clients, Startup Project for I.V. Solution Manufacturing with BFS Technology, Production of I.V. Fluids (Saline and Dextrose), Intravenous Solution (IV) Manufacturing Business with Blow-Fill-Seal (BFS) Technology
Plant capacity: 48,000 Bottles/Day 500 ml each bottlePlant & machinery: 253.00 Lakhs
Working capital: N/AT.C.I: Cost of Project 834.00Lakhs
Return: 29.00%Break even: 52.00%
Add to Inquiry Add to Inquiry Basket

I.V. Fluids (BFS Technology)

Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. Fluids are given when someone's body fluid volume falls. There are a number of things which can cause a drop in fluid volume. Vomiting and diarrhea are a classic example, which is why people are encouraged to drink fluids when they are sick, to keep their fluid volume stable. Intravenous fluids can also be used as a route of medication administration. The Indian pharmaceutical industry is the fourth largest in the world in terms of volume of output and thirteenth in domestic demand. However, the Indian industry, valued at USD 17 bn in represented just over 1% of the global pharmaceutical industry (USD 1700 bn) in value terms. The domestic market is estimated at Rs 680 bn. India has the world's third largest active pharmaceutical ingredients (API) for the industry valued at a little less than USD 2 bn. These new business streams would help growth in future earnings. Intravenous (IV) fluids market in India is around Rs. 3,000 crore growing at healthy rate of around 15-20 per cent a year due to its essential requirement in nature. Which facilitates the development of new technologies and ensure a high quality product. Few Indian major players are as under • Abaris Healthcare Pvt. Ltd. • Ahlcon Parenterals (India) Ltd. • Axa Parenterals Ltd. • Infutec Healthcare Ltd. • Kokad Pharmaceutical Laboratories Ltd. • Parenteral Surgicals Ltd. • Punjab Formulations Ltd.
Plant capacity: I.V. Fluid (500 ml.): 48000 Bottles /DayPlant & machinery: Rs 252 lakhs
Working capital: N/AT.C.I: Cost of Project: Rs 833 lakhs
Return: 29.00%Break even: 52.00%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 11 of 12 | Total 113 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Section of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top

Products & Services

Others

Contact Us

My Account

Help

Payment Options

  • Credit Cards
  • Debit Cards
  • PayPal
  • Net Banking - (All Major Indian Banks)

We Process

  • Cards

Google Search


Search Project Reports & Profiles





Subjects